Patents Assigned to BIOVIVA USA INC.
  • Methods of treating or preventing age related disorders
    Patent number: 11266721
    Abstract: This invention relates to the treatment of age-related disorders with a combination of the hTERT gene and the Follistatin gene in a delivery system such as in an adeno-associated viral vector. The Follistatin gene is expected to promote the division of stem cells that will regenerate the organism and the hTERT will prevent their depletion.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: March 8, 2022
    Assignee: BIOVIVA USA INC.
    Inventor: Elizabeth Louise Parrish